Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.32 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.32 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.32 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.32 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4779396 | 0.86 | CYP1A2 (0.43) | PMP22SLC1A2SLC1A1SLC1A3GRIK1 | |
| SCHEMBL8633798 | 0.85 | KMT2A (0.42) | ALOX15BLMPMP22KMT2ASLC1A2 | |
| SCHEMBL5988400 | 0.82 | KMT2A (0.47) | ALOX15BLMPMP22KMT2ASLC1A2 | |
| SCHEMBL2244866 | 0.82 | KMT2A (0.47) | ALOX15BLMPMP22KMT2ASLC1A2 | |
| SCHEMBL27774327 | 0.82 | KMT2A (0.47) | ALOX15BLMPMP22KMT2ASLC1A2 | |
| SCHEMBL5495885 | 0.81 | NOD1 (0.42) | ALOX15BLMPMP22KMT2ASLC1A2 | |
| SCHEMBL5495880 | 0.81 | NOD1 (0.42) | ALOX15BLMPMP22KMT2ASLC1A2 | |
| SCHEMBL3335954 | 0.81 | ALOX15 (0.45) | ALOX15BLMPMP22KMT2ASLC1A2 | |
| SCHEMBL17772936 | 0.81 | ALOX15 (0.45) | ALOX15BLMPMP22KMT2ASLC1A2 | |
| SCHEMBL1221384 | 0.81 | ALOX15 (0.45) | ALOX15BLMPMP22KMT2ASLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220071917-A9 | DRUG DELIVERY SYSTEMS AND METHODS COMPRISING POLYSIALIC ACID AND/OR OTHER POLYMERS | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2022-03-10 | — | — | US | disclosed |
| US-20210228494-A1 | DRUG DELIVERY SYSTEMS AND METHODS COMPRISING POLYSIALIC ACID AND/OR OTHER POLYMERS | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2021-07-29 | — | — | US | disclosed |
| EP-3703666-A1 | DRUG DELIVERY SYSTEMS AND METHODS COMPRISING POLYSIALIC ACID AND/OR OTHER POLYMERS | Universidade de Santiago de Compostela (ES) | 2020-09-09 | — | — | EP | disclosed |
| EP-2664324-B1 | NANOCAPSULES WITH A POLYMER SHELL | UNIV SANTIAGO COMPOSTELA (ES) | 2019-09-25 | — | — | EP | disclosed |
| US-9415019-B2 | Nanocapsules with a polymer shell | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2016-08-16 | — | — | US | disclosed |
| US-20140023703-A1 | NANOCAPSULES WITH A POLYMER SHELL | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2014-01-23 | — | — | US | disclosed |
| EP-2664324-A1 | NANOCAPSULES WITH A POLYMER SHELL | Universidade De Santiago De Compostela (ES) | 2013-11-20 | — | — | EP | disclosed |
| US-20050090512-A1 | Method of treating extreme physical or mental stress using L-theanine to obtain accelerated regeneration | ISME PRIVATES FORSCHUNGSINSTITUT FUR SPORT MEDIZIN UND ERNAHRUNG GMBH (DE) | 2005-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210228494-A1 | DRUG DELIVERY SYSTEMS AND METHODS COMPRISING POLYSIALIC ACID AND/OR OTHER POLYMERS | LNPEP, CLIC1, CLSPN | ALOX15 1106/4885BLM 4705/4885PMP22 2277/4885 |
| US-20140023703-A1 | NANOCAPSULES WITH A POLYMER SHELL | PGA5, IL15, CD44 | ALOX15 268/4885BLM 4244/4885PMP22 4143/4885 |
| US-20220071917-A9 | DRUG DELIVERY SYSTEMS AND METHODS COMPRISING POLYSIALIC ACID AND/OR OTHER POLYMERS | LNPEP, CLIC1, CLSPN | ALOX15 1106/4885BLM 4705/4885PMP22 2277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.